PPCB
Propanc Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PPCB Filings
Filing Date
Form Description
Form Type
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-10
Form 8-K - Current report
Key Events
2025-11-10 · Key Events
Form 8-K - Current report
2025-10-14
Form 8-K - Current report
Key Events
2025-10-14 · Key Events
Form 8-K - Current report
2025-09-29
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2025-09-29 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025-08-19
Form 8-K - Current report
Key Events
2025-08-19 · Key Events
Form 8-K - Current report
2025-08-19
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-19 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-18
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-08-18 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-08-18
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-08-18 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-08-14
Form CERT - Certification by an exchange approving securities for listing
2025-08-14 ·
Form CERT - Certification by an exchange approving securities for listing
